1
South University
NSG 6005
Advanced
Pharmacology
Final Exam
Question Bank
Updated 2024/2025
, 2
NSG 6005
Disease states in addition to hypertension in which beta blockade is a compelling indication for the use
of beta blockers include:
A. Heart failure
B. Angina
C. MI
D. Dyslipidemia
C. MI
When a patient is on selective-serotonin reuptake inhibitors:
A. The complete blood count must be monitored every three to four months
B. Therapeutic blood levels must be monitored every six months after a steady state is achieved.
C. Blood glucose must be monitored every three to four months.
D. There is no laboratory monitoring required.
D. There is no laboratory monitoring required.
We have an expert-written solution to this problem!
Chemical dependency assessment is integral to the initial assessment of chronic pain. Which of the
following raises a "red flag" about potential chemical dependency?
, 3
A. Use of more than one drug to treat the pain
B. Multiple times when prescriptions are lost with requests to refill
C. Preferences for treatments that include alternative medicines
D. Presence of a family member who has abused drugs
B. Multiple times when prescriptions are lost with requests to refill
Prescribing for women during their childbearing years requires constant awareness of the possibility of:
A. Pregnancy unless the women is on birth control
B. Risk for silent bacterial or viral infections of the genitalia
C. High risk for developmental disorders in their infants
D. Decreased risk for abuse during this time
B. Risk for silent bacterial or viral infections of the genitalia
First-line therapy for hyperlipidemia is:
A. Statins
B. Niacin
C. Lifestyle changes
D. Bile acid-binding resins
C. Lifestyle changes
The DEA:
A. Registers manufacturers and prescribes controlled substances
B. Regulates NP prescribing at the state level
C. Sanctions providers who prescribe drugs off-label
, 4
D. Provides prescribers with a number they can use for insurance billing
A. Registers manufacturers and prescribes controlled substances
Cecilia presents with depression associated with complaints of fatigue, sleeping all the time, and lack of
motivation. An appropriate initial antidepressant for her would be:
A. Fluoxetine (Prozac)
B. Paroxetine (Paxil)
C. Amitriptyline (Elavil)
D. Duloxetine (Cymbalta)
D. Duloxetine (Cymbalta)
Sarah, a forty-two-year-old female, requests a prescription for an anorexiant to treat her obesity. A trial
of phentermine is prescribed. Prescribing precautions include understanding that:
A. Obesity is a contraindication to prescribing phentermine.
B. Anorexiants may cause tolerance and should only be prescribed for six months.
C. Patients should be monitored for postural hypotension.
D. Renal function should be monitored closely while the patient is on anorexiants.
B. Anorexiants may cause tolerance and should only be prescribed for six months.
Patients with psychiatric illnesses have adherence rates to their drug regimen between 35% and 60%. To
improve adherence in this population, prescribe drugs:
A. With a longer half-life so that missed doses produce a longer taper on the drug curve
B. In oral formulations that are more easily taken
C. That do not require frequent monitoring
South University
NSG 6005
Advanced
Pharmacology
Final Exam
Question Bank
Updated 2024/2025
, 2
NSG 6005
Disease states in addition to hypertension in which beta blockade is a compelling indication for the use
of beta blockers include:
A. Heart failure
B. Angina
C. MI
D. Dyslipidemia
C. MI
When a patient is on selective-serotonin reuptake inhibitors:
A. The complete blood count must be monitored every three to four months
B. Therapeutic blood levels must be monitored every six months after a steady state is achieved.
C. Blood glucose must be monitored every three to four months.
D. There is no laboratory monitoring required.
D. There is no laboratory monitoring required.
We have an expert-written solution to this problem!
Chemical dependency assessment is integral to the initial assessment of chronic pain. Which of the
following raises a "red flag" about potential chemical dependency?
, 3
A. Use of more than one drug to treat the pain
B. Multiple times when prescriptions are lost with requests to refill
C. Preferences for treatments that include alternative medicines
D. Presence of a family member who has abused drugs
B. Multiple times when prescriptions are lost with requests to refill
Prescribing for women during their childbearing years requires constant awareness of the possibility of:
A. Pregnancy unless the women is on birth control
B. Risk for silent bacterial or viral infections of the genitalia
C. High risk for developmental disorders in their infants
D. Decreased risk for abuse during this time
B. Risk for silent bacterial or viral infections of the genitalia
First-line therapy for hyperlipidemia is:
A. Statins
B. Niacin
C. Lifestyle changes
D. Bile acid-binding resins
C. Lifestyle changes
The DEA:
A. Registers manufacturers and prescribes controlled substances
B. Regulates NP prescribing at the state level
C. Sanctions providers who prescribe drugs off-label
, 4
D. Provides prescribers with a number they can use for insurance billing
A. Registers manufacturers and prescribes controlled substances
Cecilia presents with depression associated with complaints of fatigue, sleeping all the time, and lack of
motivation. An appropriate initial antidepressant for her would be:
A. Fluoxetine (Prozac)
B. Paroxetine (Paxil)
C. Amitriptyline (Elavil)
D. Duloxetine (Cymbalta)
D. Duloxetine (Cymbalta)
Sarah, a forty-two-year-old female, requests a prescription for an anorexiant to treat her obesity. A trial
of phentermine is prescribed. Prescribing precautions include understanding that:
A. Obesity is a contraindication to prescribing phentermine.
B. Anorexiants may cause tolerance and should only be prescribed for six months.
C. Patients should be monitored for postural hypotension.
D. Renal function should be monitored closely while the patient is on anorexiants.
B. Anorexiants may cause tolerance and should only be prescribed for six months.
Patients with psychiatric illnesses have adherence rates to their drug regimen between 35% and 60%. To
improve adherence in this population, prescribe drugs:
A. With a longer half-life so that missed doses produce a longer taper on the drug curve
B. In oral formulations that are more easily taken
C. That do not require frequent monitoring
